Overview
Dr. Sofia Merajver received a doctoral degree in physics from the University of Maryland and a medical degree from the University of Michigan. She completed a residency in internal medicine and a fellowship in oncology at the University of Michigan before joining the faculty in 1994. Dr. Merajver, an expert in breast cancer genetics, is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center. Her research interests include the molecular genetics of breast cancer, gene function and cancer risk assessment. She enjoys literature, music and outdoor activities with her family.
Dr. Merajver is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma.
Dr. Merajver is board certified in Medical Oncology. She is actively involved in clinical research, co-authoring 143 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
Locations
1500 E Medical Center Dr, Floor 1, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Merajver has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Thyroid Cancer, Throat Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.
Rogel Cancer Center
Scott Schuetze is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.
Frequently Asked Questions about Dr. Sofia D. Merajver
How do I make an appointment with Dr. Sofia D. Merajver?
You can book an appointment with Dr. Sofia D. Merajver by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sofia D. Merajver a top-rated expert for Inflammatory Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sofia D. Merajver is classified as an Elite expert for Inflammatory Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sofia D. Merajver specialize in?
While Dr. Sofia D. Merajver is a Oncology, they have specific expertise in Inflammatory Breast Cancer, Breast Cancer, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sofia D. Merajver participate in research or clinical trials?
Yes. Dr. Sofia D. Merajver has published 143 articles and abstracts on conditions like Inflammatory Breast Cancer. You can view a list of Dr. Sofia D. Merajver's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sofia D. Merajver accept my insurance?
Dr. Sofia D. Merajver accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Merajver isElite. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Merajver isElite. Learn about Inflammatory Breast Cancer.
- Triple-Negative Breast CancerDr. Merajver isElite. Learn about Triple-Negative Breast Cancer.
- Distinguished
- AngiosarcomaDr. Merajver isDistinguished. Learn about Angiosarcoma.
- Advanced
- BRCA Positive Breast CancerDr. Merajver isAdvanced. Learn about BRCA Positive Breast Cancer.
- DICER1 SyndromeDr. Merajver isAdvanced. Learn about DICER1 Syndrome.
- HER2 Negative Breast CancerDr. Merajver isAdvanced. Learn about HER2 Negative Breast Cancer.
- Metastatic Brain TumorDr. Merajver isAdvanced. Learn about Metastatic Brain Tumor.
- Ovarian CancerDr. Merajver isAdvanced. Learn about Ovarian Cancer.
- Paget Disease of the BreastDr. Merajver isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Anal CancerDr. Merajver isExperienced. Learn about Anal Cancer.
- Bladder CancerDr. Merajver isExperienced. Learn about Bladder Cancer.
- Brain TumorDr. Merajver isExperienced. Learn about Brain Tumor.
- Breast Cancer in MenDr. Merajver isExperienced. Learn about Breast Cancer in Men.
- Desmoplastic Small Round Cell TumorDr. Merajver isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Familial Colorectal CancerDr. Merajver isExperienced. Learn about Familial Colorectal Cancer.